nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—NOS3—breast cancer	0.395	0.783	CbGaD
Tetrahydrobiopterin—NOS3—Doxorubicin—breast cancer	0.154	1	CbGbCtD
Tetrahydrobiopterin—PTGS2—breast cancer	0.11	0.217	CbGaD
Tetrahydrobiopterin—NOS3—umbilical vein—breast cancer	0.00792	0.222	CbGeAlD
Tetrahydrobiopterin—NOS3—mammary gland—breast cancer	0.00302	0.0847	CbGeAlD
Tetrahydrobiopterin—TPH1—endocrine gland—breast cancer	0.00247	0.0692	CbGeAlD
Tetrahydrobiopterin—TH—embryo—breast cancer	0.00229	0.0642	CbGeAlD
Tetrahydrobiopterin—PAH—endocrine gland—breast cancer	0.00194	0.0543	CbGeAlD
Tetrahydrobiopterin—NOS3—epithelium—breast cancer	0.00168	0.0472	CbGeAlD
Tetrahydrobiopterin—TH—endometrium—breast cancer	0.00168	0.047	CbGeAlD
Tetrahydrobiopterin—TH—pituitary gland—breast cancer	0.00152	0.0425	CbGeAlD
Tetrahydrobiopterin—TH—adrenal gland—breast cancer	0.00136	0.038	CbGeAlD
Tetrahydrobiopterin—NOS3—female reproductive system—breast cancer	0.00125	0.035	CbGeAlD
Tetrahydrobiopterin—NOS3—adrenal gland—breast cancer	0.00122	0.0342	CbGeAlD
Tetrahydrobiopterin—TH—endocrine gland—breast cancer	0.00118	0.033	CbGeAlD
Tetrahydrobiopterin—NOS3—endocrine gland—breast cancer	0.00106	0.0297	CbGeAlD
Tetrahydrobiopterin—TH—lymph node—breast cancer	0.000814	0.0228	CbGeAlD
Tetrahydrobiopterin—NOS3—lymph node—breast cancer	0.000732	0.0205	CbGeAlD
Tetrahydrobiopterin—PTGS2—embryo—breast cancer	0.000654	0.0183	CbGeAlD
Tetrahydrobiopterin—PTGS2—epithelium—breast cancer	0.000534	0.015	CbGeAlD
Tetrahydrobiopterin—PTGS2—skin of body—breast cancer	0.000508	0.0142	CbGeAlD
Tetrahydrobiopterin—PTGS2—endometrium—breast cancer	0.000479	0.0134	CbGeAlD
Tetrahydrobiopterin—PTGS2—uterus—breast cancer	0.000441	0.0124	CbGeAlD
Tetrahydrobiopterin—PTGS2—pituitary gland—breast cancer	0.000433	0.0121	CbGeAlD
Tetrahydrobiopterin—PTGS2—adipose tissue—breast cancer	0.000432	0.0121	CbGeAlD
Tetrahydrobiopterin—PTGS2—female reproductive system—breast cancer	0.000397	0.0111	CbGeAlD
Tetrahydrobiopterin—PTGS2—adrenal gland—breast cancer	0.000387	0.0108	CbGeAlD
Tetrahydrobiopterin—PTGS2—bone marrow—breast cancer	0.000374	0.0105	CbGeAlD
Tetrahydrobiopterin—PTGS2—female gonad—breast cancer	0.000361	0.0101	CbGeAlD
Tetrahydrobiopterin—PTGS2—endocrine gland—breast cancer	0.000336	0.0094	CbGeAlD
Tetrahydrobiopterin—PTGS2—lymph node—breast cancer	0.000232	0.0065	CbGeAlD
Tetrahydrobiopterin—Agitation—Paclitaxel—breast cancer	0.000132	0.000877	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Thiotepa—breast cancer	0.000132	0.000874	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Thiotepa—breast cancer	0.000132	0.000874	CcSEcCtD
Tetrahydrobiopterin—Headache—Vinblastine—breast cancer	0.000132	0.000873	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Mitoxantrone—breast cancer	0.000131	0.00087	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Tamoxifen—breast cancer	0.00013	0.00086	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Goserelin—breast cancer	0.000129	0.000855	CcSEcCtD
Tetrahydrobiopterin—Rash—Tamoxifen—breast cancer	0.000129	0.000853	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Vinorelbine—breast cancer	0.000129	0.000853	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Tamoxifen—breast cancer	0.000129	0.000852	CcSEcCtD
Tetrahydrobiopterin—Headache—Tamoxifen—breast cancer	0.000128	0.000848	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Gemcitabine—breast cancer	0.000128	0.000847	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Melphalan—breast cancer	0.000127	0.000842	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Irinotecan—breast cancer	0.000127	0.00084	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Mitoxantrone—breast cancer	0.000127	0.00084	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Doxorubicin—breast cancer	0.000127	0.000838	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Docetaxel—breast cancer	0.000126	0.000837	CcSEcCtD
Tetrahydrobiopterin—Rash—Melphalan—breast cancer	0.000126	0.000835	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Melphalan—breast cancer	0.000126	0.000835	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Fluorouracil—breast cancer	0.000126	0.000833	CcSEcCtD
Tetrahydrobiopterin—Cough—Paclitaxel—breast cancer	0.000126	0.000832	CcSEcCtD
Tetrahydrobiopterin—Nausea—Vinblastine—breast cancer	0.000125	0.000827	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Epirubicin—breast cancer	0.000125	0.000827	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Paclitaxel—breast cancer	0.000125	0.000827	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Irinotecan—breast cancer	0.000125	0.000824	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Goserelin—breast cancer	0.000124	0.000822	CcSEcCtD
Tetrahydrobiopterin—Rash—Goserelin—breast cancer	0.000123	0.000815	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Thiotepa—breast cancer	0.000123	0.000814	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Goserelin—breast cancer	0.000123	0.000814	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Paclitaxel—breast cancer	0.000123	0.000812	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Capecitabine—breast cancer	0.000122	0.00081	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Epirubicin—breast cancer	0.000122	0.00081	CcSEcCtD
Tetrahydrobiopterin—Headache—Goserelin—breast cancer	0.000122	0.00081	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Docetaxel—breast cancer	0.000122	0.000809	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000122	0.000807	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Fluorouracil—breast cancer	0.000122	0.000805	CcSEcCtD
Tetrahydrobiopterin—Nausea—Tamoxifen—breast cancer	0.000121	0.000804	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000121	0.000803	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Epirubicin—breast cancer	0.000121	0.000801	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Vinorelbine—breast cancer	0.00012	0.000792	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000119	0.000789	CcSEcCtD
Tetrahydrobiopterin—Nausea—Melphalan—breast cancer	0.000119	0.000787	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Capecitabine—breast cancer	0.000118	0.000783	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Methotrexate—breast cancer	0.000118	0.000782	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000118	0.000781	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Irinotecan—breast cancer	0.000118	0.000781	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Paclitaxel—breast cancer	0.000118	0.000779	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Methotrexate—breast cancer	0.000117	0.000777	CcSEcCtD
Tetrahydrobiopterin—Infection—Paclitaxel—breast cancer	0.000117	0.000773	CcSEcCtD
Tetrahydrobiopterin—Nausea—Goserelin—breast cancer	0.000116	0.000768	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Vinorelbine—breast cancer	0.000116	0.000765	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Doxorubicin—breast cancer	0.000116	0.000765	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Paclitaxel—breast cancer	0.000115	0.000764	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Thiotepa—breast cancer	0.000114	0.000756	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Paclitaxel—breast cancer	0.000114	0.000756	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Irinotecan—breast cancer	0.000114	0.000755	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Mitoxantrone—breast cancer	0.000114	0.000755	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Mitoxantrone—breast cancer	0.000114	0.000755	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Irinotecan—breast cancer	0.000114	0.000755	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Doxorubicin—breast cancer	0.000113	0.000749	CcSEcCtD
Tetrahydrobiopterin—Infestation—Methotrexate—breast cancer	0.000113	0.000746	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Methotrexate—breast cancer	0.000113	0.000746	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Doxorubicin—breast cancer	0.000112	0.000742	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Vinorelbine—breast cancer	0.000111	0.000736	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Gemcitabine—breast cancer	0.000111	0.000735	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Epirubicin—breast cancer	0.000111	0.000732	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Thiotepa—breast cancer	0.00011	0.000731	CcSEcCtD
Tetrahydrobiopterin—Rash—Vinorelbine—breast cancer	0.00011	0.00073	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Vinorelbine—breast cancer	0.00011	0.000729	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Epirubicin—breast cancer	0.00011	0.000727	CcSEcCtD
Tetrahydrobiopterin—Headache—Vinorelbine—breast cancer	0.00011	0.000725	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Fluorouracil—breast cancer	0.000109	0.000723	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000107	0.000709	CcSEcCtD
Tetrahydrobiopterin—Cough—Docetaxel—breast cancer	0.000107	0.000706	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Mitoxantrone—breast cancer	0.000106	0.000703	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Irinotecan—breast cancer	0.000106	0.000703	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Thiotepa—breast cancer	0.000106	0.000703	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Docetaxel—breast cancer	0.000106	0.000701	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Epirubicin—breast cancer	0.000105	0.000698	CcSEcCtD
Tetrahydrobiopterin—Infestation—Epirubicin—breast cancer	0.000105	0.000698	CcSEcCtD
Tetrahydrobiopterin—Rash—Thiotepa—breast cancer	0.000105	0.000697	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Thiotepa—breast cancer	0.000105	0.000696	CcSEcCtD
Tetrahydrobiopterin—Headache—Thiotepa—breast cancer	0.000105	0.000693	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Docetaxel—breast cancer	0.000104	0.000688	CcSEcCtD
Tetrahydrobiopterin—Nausea—Vinorelbine—breast cancer	0.000104	0.000688	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Paclitaxel—breast cancer	0.000104	0.000685	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000103	0.000684	CcSEcCtD
Tetrahydrobiopterin—Cough—Capecitabine—breast cancer	0.000103	0.000683	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Epirubicin—breast cancer	0.000102	0.000678	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Doxorubicin—breast cancer	0.000102	0.000677	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Fluorouracil—breast cancer	0.000102	0.000674	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Doxorubicin—breast cancer	0.000102	0.000673	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000102	0.000672	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Capecitabine—breast cancer	0.000101	0.000666	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Methotrexate—breast cancer	0.0001	0.000664	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.0001	0.000662	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Docetaxel—breast cancer	9.97e-05	0.00066	CcSEcCtD
Tetrahydrobiopterin—Nausea—Thiotepa—breast cancer	9.92e-05	0.000657	CcSEcCtD
Tetrahydrobiopterin—Infection—Docetaxel—breast cancer	9.91e-05	0.000656	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Mitoxantrone—breast cancer	9.87e-05	0.000653	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Irinotecan—breast cancer	9.87e-05	0.000653	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Docetaxel—breast cancer	9.78e-05	0.000647	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Doxorubicin—breast cancer	9.76e-05	0.000646	CcSEcCtD
Tetrahydrobiopterin—Infestation—Doxorubicin—breast cancer	9.76e-05	0.000646	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Docetaxel—breast cancer	9.69e-05	0.000641	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Paclitaxel—breast cancer	9.62e-05	0.000637	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Gemcitabine—breast cancer	9.61e-05	0.000636	CcSEcCtD
Tetrahydrobiopterin—Infection—Capecitabine—breast cancer	9.59e-05	0.000635	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Irinotecan—breast cancer	9.54e-05	0.000631	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Doxorubicin—breast cancer	9.48e-05	0.000628	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Capecitabine—breast cancer	9.47e-05	0.000627	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Fluorouracil—breast cancer	9.45e-05	0.000626	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Epirubicin—breast cancer	9.4e-05	0.000622	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Capecitabine—breast cancer	9.38e-05	0.000621	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Epirubicin—breast cancer	9.33e-05	0.000617	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Paclitaxel—breast cancer	9.3e-05	0.000615	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Paclitaxel—breast cancer	9.3e-05	0.000615	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Irinotecan—breast cancer	9.17e-05	0.000607	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Mitoxantrone—breast cancer	9.17e-05	0.000607	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Fluorouracil—breast cancer	9.14e-05	0.000605	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Methotrexate—breast cancer	9.12e-05	0.000603	CcSEcCtD
Tetrahydrobiopterin—Rash—Mitoxantrone—breast cancer	9.09e-05	0.000602	CcSEcCtD
Tetrahydrobiopterin—Rash—Irinotecan—breast cancer	9.09e-05	0.000602	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Irinotecan—breast cancer	9.09e-05	0.000601	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Mitoxantrone—breast cancer	9.09e-05	0.000601	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Docetaxel—breast cancer	9.08e-05	0.000601	CcSEcCtD
Tetrahydrobiopterin—Headache—Irinotecan—breast cancer	9.04e-05	0.000598	CcSEcCtD
Tetrahydrobiopterin—Headache—Mitoxantrone—breast cancer	9.04e-05	0.000598	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Gemcitabine—breast cancer	8.93e-05	0.000591	CcSEcCtD
Tetrahydrobiopterin—Rash—Gemcitabine—breast cancer	8.86e-05	0.000586	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Gemcitabine—breast cancer	8.85e-05	0.000586	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Methotrexate—breast cancer	8.81e-05	0.000583	CcSEcCtD
Tetrahydrobiopterin—Headache—Gemcitabine—breast cancer	8.8e-05	0.000583	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Capecitabine—breast cancer	8.8e-05	0.000582	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Fluorouracil—breast cancer	8.78e-05	0.000581	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Docetaxel—breast cancer	8.78e-05	0.000581	CcSEcCtD
Tetrahydrobiopterin—Rash—Fluorouracil—breast cancer	8.71e-05	0.000576	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Fluorouracil—breast cancer	8.7e-05	0.000576	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Doxorubicin—breast cancer	8.69e-05	0.000575	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Paclitaxel—breast cancer	8.67e-05	0.000574	CcSEcCtD
Tetrahydrobiopterin—Headache—Fluorouracil—breast cancer	8.65e-05	0.000573	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Doxorubicin—breast cancer	8.63e-05	0.000571	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Docetaxel—breast cancer	8.61e-05	0.00057	CcSEcCtD
Tetrahydrobiopterin—Nausea—Mitoxantrone—breast cancer	8.57e-05	0.000567	CcSEcCtD
Tetrahydrobiopterin—Nausea—Irinotecan—breast cancer	8.57e-05	0.000567	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Epirubicin—breast cancer	8.53e-05	0.000565	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Capecitabine—breast cancer	8.5e-05	0.000562	CcSEcCtD
Tetrahydrobiopterin—Nausea—Gemcitabine—breast cancer	8.35e-05	0.000552	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Capecitabine—breast cancer	8.33e-05	0.000552	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Epirubicin—breast cancer	8.24e-05	0.000545	CcSEcCtD
Tetrahydrobiopterin—Nausea—Fluorouracil—breast cancer	8.21e-05	0.000543	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Docetaxel—breast cancer	8.15e-05	0.00054	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Paclitaxel—breast cancer	8.05e-05	0.000533	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Capecitabine—breast cancer	7.89e-05	0.000522	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Doxorubicin—breast cancer	7.89e-05	0.000522	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Docetaxel—breast cancer	7.88e-05	0.000522	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Docetaxel—breast cancer	7.88e-05	0.000522	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Paclitaxel—breast cancer	7.78e-05	0.000515	CcSEcCtD
Tetrahydrobiopterin—Cough—Methotrexate—breast cancer	7.68e-05	0.000509	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Capecitabine—breast cancer	7.63e-05	0.000505	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Capecitabine—breast cancer	7.63e-05	0.000505	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Methotrexate—breast cancer	7.63e-05	0.000505	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Doxorubicin—breast cancer	7.62e-05	0.000505	CcSEcCtD
Tetrahydrobiopterin—Agitation—Epirubicin—breast cancer	7.57e-05	0.000501	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Methotrexate—breast cancer	7.5e-05	0.000496	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Paclitaxel—breast cancer	7.48e-05	0.000495	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	7.45e-05	0.000493	CcSEcCtD
Tetrahydrobiopterin—Rash—Paclitaxel—breast cancer	7.42e-05	0.000491	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Paclitaxel—breast cancer	7.41e-05	0.00049	CcSEcCtD
Tetrahydrobiopterin—Headache—Paclitaxel—breast cancer	7.37e-05	0.000488	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Docetaxel—breast cancer	7.35e-05	0.000486	CcSEcCtD
Tetrahydrobiopterin—Cough—Epirubicin—breast cancer	7.19e-05	0.000476	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Methotrexate—breast cancer	7.19e-05	0.000476	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Epirubicin—breast cancer	7.14e-05	0.000473	CcSEcCtD
Tetrahydrobiopterin—Infection—Methotrexate—breast cancer	7.14e-05	0.000473	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Capecitabine—breast cancer	7.11e-05	0.000471	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Methotrexate—breast cancer	7.05e-05	0.000466	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Epirubicin—breast cancer	7.02e-05	0.000464	CcSEcCtD
Tetrahydrobiopterin—Agitation—Doxorubicin—breast cancer	7.01e-05	0.000464	CcSEcCtD
Tetrahydrobiopterin—Nausea—Paclitaxel—breast cancer	6.99e-05	0.000462	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Methotrexate—breast cancer	6.98e-05	0.000462	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	6.97e-05	0.000461	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Docetaxel—breast cancer	6.82e-05	0.000452	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Epirubicin—breast cancer	6.73e-05	0.000445	CcSEcCtD
Tetrahydrobiopterin—Infection—Epirubicin—breast cancer	6.68e-05	0.000442	CcSEcCtD
Tetrahydrobiopterin—Cough—Doxorubicin—breast cancer	6.65e-05	0.00044	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Doxorubicin—breast cancer	6.61e-05	0.000437	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Capecitabine—breast cancer	6.61e-05	0.000437	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Epirubicin—breast cancer	6.6e-05	0.000437	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Docetaxel—breast cancer	6.59e-05	0.000436	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Methotrexate—breast cancer	6.55e-05	0.000433	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Epirubicin—breast cancer	6.53e-05	0.000432	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Doxorubicin—breast cancer	6.49e-05	0.00043	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	6.45e-05	0.000427	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Capecitabine—breast cancer	6.38e-05	0.000423	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Docetaxel—breast cancer	6.34e-05	0.00042	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Methotrexate—breast cancer	6.33e-05	0.000419	CcSEcCtD
Tetrahydrobiopterin—Rash—Docetaxel—breast cancer	6.29e-05	0.000416	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Docetaxel—breast cancer	6.28e-05	0.000416	CcSEcCtD
Tetrahydrobiopterin—Headache—Docetaxel—breast cancer	6.25e-05	0.000413	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Doxorubicin—breast cancer	6.22e-05	0.000412	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Methotrexate—breast cancer	6.2e-05	0.000411	CcSEcCtD
Tetrahydrobiopterin—Infection—Doxorubicin—breast cancer	6.18e-05	0.000409	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Capecitabine—breast cancer	6.14e-05	0.000406	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Epirubicin—breast cancer	6.13e-05	0.000406	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Doxorubicin—breast cancer	6.1e-05	0.000404	CcSEcCtD
Tetrahydrobiopterin—Rash—Capecitabine—breast cancer	6.09e-05	0.000403	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Capecitabine—breast cancer	6.08e-05	0.000402	CcSEcCtD
Tetrahydrobiopterin—Headache—Capecitabine—breast cancer	6.05e-05	0.0004	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Doxorubicin—breast cancer	6.04e-05	0.0004	CcSEcCtD
Tetrahydrobiopterin—Nausea—Docetaxel—breast cancer	5.92e-05	0.000392	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Epirubicin—breast cancer	5.92e-05	0.000392	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Methotrexate—breast cancer	5.88e-05	0.000389	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Epirubicin—breast cancer	5.81e-05	0.000384	CcSEcCtD
Tetrahydrobiopterin—Nausea—Capecitabine—breast cancer	5.73e-05	0.00038	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Methotrexate—breast cancer	5.68e-05	0.000376	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Methotrexate—breast cancer	5.68e-05	0.000376	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Doxorubicin—breast cancer	5.67e-05	0.000375	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Epirubicin—breast cancer	5.5e-05	0.000364	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Doxorubicin—breast cancer	5.48e-05	0.000363	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Doxorubicin—breast cancer	5.37e-05	0.000356	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Epirubicin—breast cancer	5.32e-05	0.000352	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Epirubicin—breast cancer	5.32e-05	0.000352	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Methotrexate—breast cancer	5.29e-05	0.00035	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Doxorubicin—breast cancer	5.09e-05	0.000337	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Epirubicin—breast cancer	4.95e-05	0.000328	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Doxorubicin—breast cancer	4.92e-05	0.000326	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Doxorubicin—breast cancer	4.92e-05	0.000326	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Methotrexate—breast cancer	4.92e-05	0.000325	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Methotrexate—breast cancer	4.75e-05	0.000315	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Epirubicin—breast cancer	4.6e-05	0.000305	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Doxorubicin—breast cancer	4.58e-05	0.000303	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Methotrexate—breast cancer	4.57e-05	0.000302	CcSEcCtD
Tetrahydrobiopterin—Rash—Methotrexate—breast cancer	4.53e-05	0.0003	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Methotrexate—breast cancer	4.53e-05	0.0003	CcSEcCtD
Tetrahydrobiopterin—Headache—Methotrexate—breast cancer	4.5e-05	0.000298	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Epirubicin—breast cancer	4.45e-05	0.000294	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Epirubicin—breast cancer	4.28e-05	0.000283	CcSEcCtD
Tetrahydrobiopterin—Nausea—Methotrexate—breast cancer	4.27e-05	0.000283	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Doxorubicin—breast cancer	4.26e-05	0.000282	CcSEcCtD
Tetrahydrobiopterin—Rash—Epirubicin—breast cancer	4.24e-05	0.000281	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Epirubicin—breast cancer	4.24e-05	0.00028	CcSEcCtD
Tetrahydrobiopterin—Headache—Epirubicin—breast cancer	4.21e-05	0.000279	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Doxorubicin—breast cancer	4.12e-05	0.000272	CcSEcCtD
Tetrahydrobiopterin—Nausea—Epirubicin—breast cancer	3.99e-05	0.000264	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Doxorubicin—breast cancer	3.96e-05	0.000262	CcSEcCtD
Tetrahydrobiopterin—Rash—Doxorubicin—breast cancer	3.92e-05	0.00026	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Doxorubicin—breast cancer	3.92e-05	0.000259	CcSEcCtD
Tetrahydrobiopterin—Headache—Doxorubicin—breast cancer	3.9e-05	0.000258	CcSEcCtD
Tetrahydrobiopterin—Nausea—Doxorubicin—breast cancer	3.7e-05	0.000245	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Metabolism—GPX4—breast cancer	1.01e-05	6.5e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IGF1R—breast cancer	1.01e-05	6.49e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—PIK3CA—breast cancer	1e-05	6.49e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ALDOA—breast cancer	1e-05	6.48e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HES1—breast cancer	9.87e-06	6.38e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—JAG2—breast cancer	9.87e-06	6.38e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—IDH1—breast cancer	9.83e-06	6.35e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTA1—breast cancer	9.83e-06	6.35e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	9.83e-06	6.35e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NCOR1—breast cancer	9.82e-06	6.34e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PLA2G4A—breast cancer	9.82e-06	6.34e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—BRAF—breast cancer	9.78e-06	6.32e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	9.75e-06	6.3e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—WNT1—breast cancer	9.73e-06	6.29e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NAT2—breast cancer	9.72e-06	6.28e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—KRAS—breast cancer	9.72e-06	6.28e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—TP53—breast cancer	9.72e-06	6.28e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CSF2—breast cancer	9.71e-06	6.27e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FGF1—breast cancer	9.71e-06	6.27e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SLC2A2—breast cancer	9.66e-06	6.24e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PIK3CB—breast cancer	9.64e-06	6.23e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NRG1—breast cancer	9.64e-06	6.23e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CAV1—breast cancer	9.57e-06	6.18e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—H2AFX—breast cancer	9.57e-06	6.18e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTGS2—breast cancer	9.55e-06	6.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—AKT2—breast cancer	9.52e-06	6.15e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—E2F1—breast cancer	9.5e-06	6.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MTR—breast cancer	9.46e-06	6.11e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—HRAS—breast cancer	9.29e-06	6e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3CD—breast cancer	9.15e-06	5.91e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SPP1—breast cancer	9.13e-06	5.9e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—SERPINE1—breast cancer	9.05e-06	5.85e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ERBB3—breast cancer	9.03e-06	5.83e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FGFR2—breast cancer	9.01e-06	5.82e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	8.95e-06	5.79e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PIK3CA—breast cancer	8.93e-06	5.77e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HSPA1B—breast cancer	8.8e-06	5.68e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	8.79e-06	5.68e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CG—breast cancer	8.72e-06	5.63e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	8.66e-06	5.6e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TERT—breast cancer	8.65e-06	5.59e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—DPYD—breast cancer	8.52e-06	5.51e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—MED12—breast cancer	8.52e-06	5.51e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ENO1—breast cancer	8.43e-06	5.45e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FGFR1—breast cancer	8.4e-06	5.43e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ALDOA—breast cancer	8.39e-06	5.42e-05	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—AKT1—breast cancer	8.36e-06	5.4e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTEN—breast cancer	8.33e-06	5.38e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HIF1A—breast cancer	8.27e-06	5.35e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—HRAS—breast cancer	8.26e-06	5.34e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—AKT1—breast cancer	8.2e-06	5.3e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MDM2—breast cancer	8.2e-06	5.3e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—RAF1—breast cancer	8.17e-06	5.28e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NCOA3—breast cancer	8.15e-06	5.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SLC2A2—breast cancer	8.09e-06	5.23e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—ERBB2—breast cancer	8.08e-06	5.22e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—LEP—breast cancer	8.08e-06	5.22e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	8e-06	5.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CAV1—breast cancer	8e-06	5.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MTOR—breast cancer	7.98e-06	5.15e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3CB—breast cancer	7.98e-06	5.15e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FGF3—breast cancer	7.97e-06	5.15e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CD4—breast cancer	7.96e-06	5.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ABCG2—breast cancer	7.92e-06	5.12e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—MTR—breast cancer	7.92e-06	5.12e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CPT1A—breast cancer	7.92e-06	5.12e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KDR—breast cancer	7.91e-06	5.11e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—IL6—breast cancer	7.91e-06	5.11e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTGS2—breast cancer	7.9e-06	5.11e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—JAG1—breast cancer	7.87e-06	5.09e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FASN—breast cancer	7.87e-06	5.09e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PARP1—breast cancer	7.84e-06	5.07e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HPGDS—breast cancer	7.77e-06	5.02e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CALCA—breast cancer	7.74e-06	5e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HBA1—breast cancer	7.72e-06	4.99e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ESR1—breast cancer	7.71e-06	4.98e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CD—breast cancer	7.66e-06	4.95e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—RPS6—breast cancer	7.65e-06	4.95e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FN1—breast cancer	7.62e-06	4.92e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FGF4—breast cancer	7.59e-06	4.91e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—ALB—breast cancer	7.56e-06	4.89e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CXCR4—breast cancer	7.56e-06	4.89e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTT1—breast cancer	7.54e-06	4.87e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ACHE—breast cancer	7.54e-06	4.87e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NFKBIA—breast cancer	7.53e-06	4.86e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CDKN1B—breast cancer	7.48e-06	4.84e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SLC2A1—breast cancer	7.48e-06	4.83e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PIK3CA—breast cancer	7.48e-06	4.83e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NOTCH1—breast cancer	7.45e-06	4.82e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	7.31e-06	4.73e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—AKT1—breast cancer	7.29e-06	4.71e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TCF7L2—breast cancer	7.29e-06	4.71e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CG—breast cancer	7.29e-06	4.71e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KIT—breast cancer	7.29e-06	4.71e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—APC—breast cancer	7.29e-06	4.71e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EGF—breast cancer	7.2e-06	4.66e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP17A1—breast cancer	7.13e-06	4.61e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CTNNB1—breast cancer	7.07e-06	4.57e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ENO1—breast cancer	7.06e-06	4.56e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PTGS1—breast cancer	7.06e-06	4.56e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	7.04e-06	4.55e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HSP90AA1—breast cancer	7.03e-06	4.54e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—ALB—breast cancer	6.95e-06	4.49e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP2D6—breast cancer	6.93e-06	4.48e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CDKN1A—breast cancer	6.91e-06	4.46e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTEN—breast cancer	6.89e-06	4.45e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—BRAF—breast cancer	6.85e-06	4.43e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PRL—breast cancer	6.84e-06	4.42e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NCOA2—breast cancer	6.8e-06	4.39e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ADAM10—breast cancer	6.74e-06	4.36e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CB—breast cancer	6.68e-06	4.32e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IGF1—breast cancer	6.67e-06	4.31e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—AKT2—breast cancer	6.67e-06	4.31e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTGS2—breast cancer	6.62e-06	4.28e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—FASN—breast cancer	6.59e-06	4.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—BCHE—breast cancer	6.57e-06	4.24e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FGF10—breast cancer	6.56e-06	4.24e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SLC5A5—breast cancer	6.49e-06	4.19e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CD—breast cancer	6.41e-06	4.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—SRC—breast cancer	6.39e-06	4.13e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SERPINE1—breast cancer	6.34e-06	4.1e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PDGFA—breast cancer	6.33e-06	4.09e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SLC2A1—breast cancer	6.26e-06	4.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NQO1—breast cancer	6.26e-06	4.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TGFBR2—breast cancer	6.24e-06	4.03e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—STAT3—breast cancer	6.16e-06	3.98e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ITPR1—breast cancer	6.14e-06	3.97e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	6.13e-06	3.96e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—AKT1—breast cancer	6.11e-06	3.95e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP3A4—breast cancer	6.11e-06	3.95e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ERBB4—breast cancer	6.1e-06	3.94e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—STAT5A—breast cancer	6.1e-06	3.94e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP1B1—breast cancer	6.01e-06	3.88e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SMAD4—breast cancer	5.91e-06	3.82e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HSP90AA1—breast cancer	5.89e-06	3.81e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MAPK3—breast cancer	5.89e-06	3.81e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PIK3CA—breast cancer	5.87e-06	3.8e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTEN—breast cancer	5.77e-06	3.73e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HES1—breast cancer	5.77e-06	3.73e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MDM2—breast cancer	5.74e-06	3.71e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NCOR1—breast cancer	5.73e-06	3.7e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NCOA1—breast cancer	5.73e-06	3.7e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MYC—breast cancer	5.73e-06	3.7e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—RAF1—breast cancer	5.72e-06	3.7e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—TGFB1—breast cancer	5.71e-06	3.69e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—RELA—breast cancer	5.7e-06	3.68e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FGF1—breast cancer	5.67e-06	3.66e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ERBB2—breast cancer	5.66e-06	3.66e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP19A1—breast cancer	5.65e-06	3.65e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—STK11—breast cancer	5.65e-06	3.65e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NRG1—breast cancer	5.63e-06	3.64e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—EGFR—breast cancer	5.6e-06	3.62e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—H2AFX—breast cancer	5.59e-06	3.61e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MTOR—breast cancer	5.59e-06	3.61e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CB—breast cancer	5.59e-06	3.61e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ERCC2—breast cancer	5.39e-06	3.48e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CXCL8—breast cancer	5.37e-06	3.47e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.3e-06	3.43e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—KRAS—breast cancer	5.29e-06	3.42e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ERBB3—breast cancer	5.27e-06	3.41e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FGFR2—breast cancer	5.26e-06	3.4e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—COMT—breast cancer	5.25e-06	3.39e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CDKN1B—breast cancer	5.24e-06	3.39e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTP1—breast cancer	5.22e-06	3.38e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HMOX1—breast cancer	5.15e-06	3.33e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ITPR1—breast cancer	5.14e-06	3.32e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CASP3—breast cancer	5.14e-06	3.32e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL2—breast cancer	5.13e-06	3.31e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MTHFR—breast cancer	5.07e-06	3.27e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TERT—breast cancer	5.05e-06	3.27e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CCND1—breast cancer	5e-06	3.23e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—JUN—breast cancer	4.99e-06	3.22e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CTNNB1—breast cancer	4.95e-06	3.2e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ABCB1—breast cancer	4.95e-06	3.2e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FGFR1—breast cancer	4.91e-06	3.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3CA—breast cancer	4.86e-06	3.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—TYMS—breast cancer	4.86e-06	3.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MMP9—breast cancer	4.85e-06	3.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CDKN1A—breast cancer	4.84e-06	3.13e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HIF1A—breast cancer	4.83e-06	3.12e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PTEN—breast cancer	4.83e-06	3.12e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PLA2G4A—breast cancer	4.8e-06	3.1e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NCOR1—breast cancer	4.8e-06	3.1e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTM1—breast cancer	4.8e-06	3.1e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—AKT1—breast cancer	4.8e-06	3.1e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MAPK8—breast cancer	4.72e-06	3.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CAV1—breast cancer	4.67e-06	3.02e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GPX1—breast cancer	4.6e-06	2.97e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP1A1—breast cancer	4.55e-06	2.94e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ERCC2—breast cancer	4.51e-06	2.92e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—HRAS—breast cancer	4.5e-06	2.91e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SRC—breast cancer	4.48e-06	2.89e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NOS2—breast cancer	4.4e-06	2.84e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—VEGFA—breast cancer	4.36e-06	2.82e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NOTCH1—breast cancer	4.35e-06	2.81e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—STAT3—breast cancer	4.32e-06	2.79e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—IL6—breast cancer	4.31e-06	2.78e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—APC—breast cancer	4.26e-06	2.75e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—KIT—breast cancer	4.26e-06	2.75e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—MTHFR—breast cancer	4.24e-06	2.74e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—EGF—breast cancer	4.21e-06	2.72e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MAPK3—breast cancer	4.12e-06	2.66e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CA—breast cancer	4.07e-06	2.63e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MYC—breast cancer	4.01e-06	2.59e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—BRAF—breast cancer	4e-06	2.59e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TGFB1—breast cancer	4e-06	2.59e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—AKT1—breast cancer	3.97e-06	2.57e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EGFR—breast cancer	3.92e-06	2.54e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CAV1—breast cancer	3.91e-06	2.53e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—AKT2—breast cancer	3.89e-06	2.52e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3CD—breast cancer	3.74e-06	2.42e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.74e-06	2.42e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KRAS—breast cancer	3.71e-06	2.39e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SERPINE1—breast cancer	3.7e-06	2.39e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CG—breast cancer	3.56e-06	2.3e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NOS3—breast cancer	3.53e-06	2.28e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CA—breast cancer	3.4e-06	2.2e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MDM2—breast cancer	3.35e-06	2.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—RAF1—breast cancer	3.34e-06	2.16e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—AKT1—breast cancer	3.33e-06	2.15e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ERBB2—breast cancer	3.31e-06	2.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TP53—breast cancer	3.29e-06	2.13e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MTOR—breast cancer	3.26e-06	2.11e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3CB—breast cancer	3.26e-06	2.11e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CD4—breast cancer	3.26e-06	2.1e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HRAS—breast cancer	3.15e-06	2.04e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CD—breast cancer	3.13e-06	2.03e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ALB—breast cancer	3.09e-06	2e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CDKN1B—breast cancer	3.06e-06	1.98e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL6—breast cancer	3.01e-06	1.95e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NOS3—breast cancer	2.96e-06	1.91e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CTNNB1—breast cancer	2.89e-06	1.87e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CDKN1A—breast cancer	2.82e-06	1.83e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PTEN—breast cancer	2.82e-06	1.82e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—AKT1—breast cancer	2.78e-06	1.8e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CB—breast cancer	2.73e-06	1.77e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SRC—breast cancer	2.61e-06	1.69e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—STAT3—breast cancer	2.52e-06	1.63e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MAPK3—breast cancer	2.41e-06	1.56e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PTEN—breast cancer	2.36e-06	1.53e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MYC—breast cancer	2.34e-06	1.51e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TGFB1—breast cancer	2.34e-06	1.51e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—EGFR—breast cancer	2.29e-06	1.48e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—KRAS—breast cancer	2.16e-06	1.4e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3CA—breast cancer	1.99e-06	1.28e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HRAS—breast cancer	1.84e-06	1.19e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—IL6—breast cancer	1.76e-06	1.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CA—breast cancer	1.67e-06	1.08e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—AKT1—breast cancer	1.62e-06	1.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—AKT1—breast cancer	1.36e-06	8.79e-06	CbGpPWpGaD
